Results 181 to 190 of about 129,036 (402)

Initial clinical experience with dapagliflozin in addition to optimized medical therapy in paediatric heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, has shown clinical benefits in adults with heart failure (HF), improving cardiac function, reducing HF‐related hospitalizations and enhancing survival rates. While extensively studied in adult HF, data on its efficacy and safety in paediatric HF patients remain limited. We
Lisa‐Maria Rosenthal   +5 more
wiley   +1 more source

Stem Cell Therapy in Critical Limb Ischemia. [PDF]

open access: yesCureus, 2023
Jeyaraman M   +8 more
europepmc   +1 more source

Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia [PDF]

open access: bronze, 2004
Jyrki Virkkunen   +4 more
openalex   +1 more source

Seizures and electroencephalographic findings in inborn errors of metabolism: Clues to differential diagnosis in the neonatal period, infancy, childhood and adolescence, and review of the literature

open access: yesEpileptic Disorders, EarlyView.
Abstract Although inborn errors of metabolism (IEM) are a rare cause of epilepsy, seizures are a common presentation in these disorders. Seizures in IEM are frequently refractory to conventional anti‐seizure medication and might warrant initiation of specific treatments based on vitamins or dietary modifications or provision of alternative substrates ...
D. Kapoor   +7 more
wiley   +1 more source

Early and Five-year Amputation and Survival Rate of Diabetic Patients with Critical Limb Ischemia: Data of a Cohort Study of 564 Patients [PDF]

open access: bronze, 2006
Ezio Faglia   +9 more
openalex   +3 more sources

Postoperative Treatment of Critical Limb Ischemia [PDF]

open access: yesEuropean Journal of Vascular and Endovascular Surgery, 2012
Ali Gürbüz   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy